NCT04984044 is a NA clinical trial of Vitamin D3 in Diabetic Peripheral Neuropathy, sponsored by Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh.

Who is sponsoring NCT04984044?

NCT04984044 is sponsored by Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh.

What drugs are being tested in NCT04984044?

Interventions in NCT04984044: Vitamin D3, Placebo.

What condition does NCT04984044 study?

NCT04984044 studies Diabetic Peripheral Neuropathy.

Is NCT04984044 still recruiting?

NCT04984044 is currently completed. Last updated 21 March 2022.

Last reviewed 2022-03-21 · How we verify

NCT04984044

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effect of Vitamin D in Patients With Diabetic Peripheral Neuropathy to Alleviate Pain and Improvement of Symptoms

Completed NA Last updated 21 March 2022

What this trial tests

NA trial testing Vitamin D3 in Diabetic Peripheral Neuropathy in 72 participants. Completed in 31 January 2022.

Timeline

7 November 2020

Primary endpoint
31 January 2022

31 January 2022

Quick facts

Lead sponsor	Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	treatment
Enrollment	72
Start date	7 November 2020
Primary completion	31 January 2022
Estimated completion	31 January 2022
Sites	1 location across Bangladesh

Drugs / interventions tested

Vitamin D3 (cholecalciferol) — full drug profile →
Placebo

Conditions studied

Diabetic Peripheral Neuropathy — all drugs for Diabetic Peripheral Neuropathy →

Sponsor

Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh

Who can join

Adults 30 to 70, any sex, with Diabetic Peripheral Neuropathy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Diabetic peripheral neuropathy(DPN) is one of the major complications of diabetes mellitus which accelerates the occurrence of ulceration of diabetic foot and amputation of lower extremities as well as severely affects the quality of life. The treatment of this condition has remained unsatisfactory with a good response to conventional medications. It is now evident that vitamin D deficiency is common in diabetic patients and especially in these patients diagnosed with diabetic peripheral neuropathy. The present research is therefore designed to observe the effect of exogenous administration of vitamin D in diabetic peripheral neuropathy patients of Bangladesh.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Innovative strategies for diabetic peripheral neuropathy: From clinical management to emerging bioengineering solutions.
He Z, Diao J, Hamel FG, Duan B. · · 2026 · PMID 41737633 · DOI 10.1016/j.bioactmat.2026.02.023

Verify or expand the search:

Other trials of Vitamin D3

Trials testing the same drug.

NCT06201013 — Vitamin D Treat-to-Target Strategy for Children With Overactive Bladder-Wet · NA · recruiting
NCT07460336 — Effects of Cofrogliptin on Beta-Cell Function in LADA Patients · NA · not yet recruiting
NCT07006714 — Preoperative Correction of Vitamin D Deficiency in Total Joint Arthroplasty (TJA) · Phase 4 · active not recruiting
NCT07269223 — Oral Vitamin D3 Effect on Inflammatory Biomarkers in Ulcerative Colitis Patients · NA · recruiting
NCT07048860 — ICOPE INTENSE-K Pilot Study · NA · recruiting

Other recruiting trials for Diabetic Peripheral Neuropathy

Currently open trials in the same condition.

NCT07380880 — Comparison of Proprioceptive Neuromuscular Training and Sensory Re-education in Patients With Diabetic Peripheral Neurop · NA · recruiting
NCT06591780 — Innovative Multi-Variable Biofeedback for Improving Gait Performance in Individuals With Diabetic Peripheral Neuropathy · NA · recruiting
NCT07036796 — Effect of Melatonin in Patients With Diabetic Peripheral Neuropathy · Phase 2 · recruiting
NCT07085130 — The Effect of Hand and Foot Exercises Combined With Cold Application or Virtual Reality on Diabetic Neuropathy · NA · active not recruiting
NCT06483620 — Cross-cultural Adaptation and Validity of the Arabic-translated NEUROPATHY-SPECIFIC QUALITY OF LIFE Questionnaire · recruiting

Other Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh trials

Trials by the same sponsor.

NCT07507045 — Education-Based Oral Health Promotion Intervention During Pregnancy: Implementation Protocol in Bangladesh · NA · not yet recruiting
NCT07537634 — Vonoprazan-based Versus Esomeprazole-based Triple Therapy for Helicobacter Pylori Eradication · Phase 4 · not yet recruiting
NCT07161336 — Role of Methotrexate in Ultrasound Proven Synovitis in Primary Knee OA · Phase 2 · recruiting
NCT06960694 — Effect of L-carnitine on Disease Activity in Patients With Mild to Moderate Knee Osteoarthritis · Phase 2 · completed
NCT07123922 — Effect of Silymarin as Add on Therapy on Oxidative Stress, Pulmonary Function and Quality of Life in Stable COPD Patient · NA · enrolling by invitation

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04984044 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
Last refreshed: 21 March 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04984044.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing